Isotretinoin (Roaccutane▼): MHRA calls for contributions to expert review
MHRA invites healthcare professionals to contribute views and information to its review on isotretinoin following concerns about the possible association between isotretinoin and suspected psychiatric and sexual disorders.
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
